STRS Ohio’s Palvella Therapeutics PVLA Stock Holding History

STRS Ohio’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,749	Closed	-$359K	–	2451
2021 Q1	$359K	Hold	1,749	–	–	﹤0.01%	1668
2020 Q4	$349K	Hold	1,749	–	–	﹤0.01%	1612
2020 Q3	$289K	Hold	1,749	–	–	﹤0.01%	1576
2020 Q2	$433K	Hold	1,749	–	–	﹤0.01%	1401
2020 Q1	$318K	Hold	1,749	–	–	﹤0.01%	1425
2019 Q4	$506K	Buy	1,749 +430	+33%	+$119K	﹤0.01%	1446
2019 Q3	$359K	Sell	1,319 -92	-7%	-$35.6K	﹤0.01%	1458
2019 Q2	$530K	Buy	1,411 +98	+7%	+$29.2K	﹤0.01%	1275
2019 Q1	$351K	Hold	1,313	–	–	﹤0.01%	1482
2018 Q4	$279K	Hold	1,313	–	–	﹤0.01%	1537
2018 Q3	$588K	Hold	1,313	–	–	﹤0.01%	1292
2018 Q2	$532K	Buy	1,313 +145	+12%	+$69K	﹤0.01%	1341
2018 Q1	$636K	Sell	1,168 -242	-17%	-$150K	﹤0.01%	1211
2017 Q4	$851K	Buy	1,410 +1,285	+1,028%	+$597K	﹤0.01%	957
2017 Q3	$57K	Hold	125	–	–	﹤0.01%	1761
2017 Q2	$50K	Buy	+125	New	+$36.5K	﹤0.01%	1792

Other funds holding PVLA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

STRS Ohio's PVLA Position: Q2 2021 in Review

STRS Ohio sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 1,749 shares — an estimated $359K sold.

STRS Ohio first reported a position in PVLA in Q2 2017 and held it in 16 quarters. The position peaked at $851K in Q4 2017. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.

STRS Ohio reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 1,749 Palvella Therapeutics shares in Q2 2021, an estimated $359K.
STRS Ohio first reported a position in Palvella Therapeutics in Q2 2017 and held it in 16 quarters.
STRS Ohio's Palvella Therapeutics position peaked at $851K in Q4 2017.
73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.